Home-based TB prevention for families
Part of Infections clinical trials.
This trial tests whether providing tuberculosis preventive treatment at home, instead of at a clinic, can help protect children under 15 who live with an adult who has recently been diagnosed with pulmonary TB. The goal is to make it easier for families to access care and stop TB from spreading.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and have been diagnosed with pulmonary TB in the past month
- You live within the facility's catchment area (the area served by the clinic)
- You have at least one child under 15 living with you
- You are willing to have a home visit and agree to participate in the study
- Children are not eligible if they have drug-resistant TB or a medical condition that makes TB prevention unsafe, or if they are already being treated for TB
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new ways to diagnose and monitor tuberculosis (TB) in children under 15 who might have TB in their lungs. The goal is to improve how we find and treat TB so children get better faster.
This trial tests a very short (one-month) medicine course to prevent tuberculosis (TB) in students and school staff who have been exposed to someone with active TB. If you have latent TB infection (the germs are in your body but you're not sick), this treatment aims to stop it from turning into active TB disease.
This trial tests if a short course of medication can prevent tuberculosis (TB) in children and teenagers who have been in close contact with someone who has active TB. The goal is to see if this approach can stop them from developing the disease.
This study looks for TB bacteria in the blood of people with active tuberculosis and their close contacts at home. It aims to find better ways to detect TB early and prevent its spread.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This study tests a daily combination of two medicines, rifapentine and isoniazid (called 1HP), to prevent tuberculosis (TB) in children under 13 years old. It includes children who have been exposed to TB or are at high risk, both those living with HIV and those without HIV.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.